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The role of six negatively charged residues located in
or around the fifth and sixth transmembrane domain of
the catalytic subunit of gastric H1,K1-ATPase, which
are conserved in P-type ATPases, was investigated by
site-directed mutagenesis of each of these residues. The
acid residues were converted into their corresponding
acid amides. Sf9 cells were used as the expression sys-
tem using a baculovirus with coding sequences for the a-
and b-subunits of H1,K1-ATPase behind two different
promoters. Both subunits of all mutants were expressed
like the wild type enzyme in intracellular membranes of
Sf9 cells as indicated by Western blotting experiments,
an enzyme-linked immunosorbent assay, and confocal
laser scan microscopy studies. The mutants D824N,
E834Q, E837Q, and D839N showed no 3-(cyanomethyl)-2-
methyl-8(phenylmethoxy)-imidazo[1,2a]pyridine (SCH
28080)-sensitive ATP dependent phosphorylation capac-
ity. Mutants E795Q and E820Q formed a phosphorylated
intermediate, which, like the wild type enzyme, was hy-
droxylamine-sensitive, indicating that an acylphos-
phate was formed. Formation of the phosphorylated in-
termediate from the E795Q mutant was similarly
inhibited by K1 (I50 5 0.4 mM) and SCH 28080 (I50 5 10
nM) as the wild type enzyme, when the membranes were
preincubated with these ligands before phosphoryla-
tion. The dephosphorylation reaction was K1-sensitive,
whereas ADP had hardly any effect. Formation of the
phosphorylated intermediate of mutant E820Q was
much less sensitive toward K1 (I50 5 4.5 mM) and SCH
28080 (I50 5 1.7 mM) than the wild type enzyme. The
dephosphorylation reaction of this intermediate was
not stimulated by either K1 or ADP. In contrast to the
wild type enzyme and mutant E795Q, mutant E820Q did
not show any K1-stimulated ATPase activity. These find-
ings indicate that residue Glu820 might be involved in K1
binding and transition to the E2 form of gastric
H1,K1-ATPase.
Transport ATPases are able to convert the energy from ATP
into active ion transport. ATPases of the P-type class (1) form
an acid-stable phosphorylated intermediate during the cata-
lytic cycle. This phosphorylated intermediate contains an as-
partyl phosphate residue present in a conserved domain in the
large intracellular loop, which in mammalian P-type ATPases
is located between the fourth and fifth transmembrane seg-
ments of the catalytic subunit (2).
Phosphorylation of this residue and ion transport are cou-
pled in such a way that specific binding of the cation that has
to be transported to the extracellular or intravesicular medium
stimulates phosphorylation, whereas binding of the cation to be
transported into the cytosol stimulates dephosphorylation. The
latter process has only been demonstrated unequivocally in
Na1,K1-ATPase and the gastric H1,K1-ATPase. The molecu-
lar mechanism of the coupling between the phosphorylation
process on the one side and ion binding and transport on the
other side is still far from being elucidated.
It is generally assumed that polar amino acid residues pres-
ent in the transmembrane domains might play a key role in
transmembrane ion transport. In particular, negatively
charged residues like those originating from aspartate and
glutamate are likely candidates for such a role (3, 4). The
presence of four transmembrane segments in the N-terminal
part of the catalytic subunits of these proteins is generally
accepted. In these four transmembrane regions there is only
one conserved negatively charged amino acid residue, which
might be involved in transmembrane ion transport (3, 5–8). In
the C-terminal part of the catalytic subunit, however, the sec-
ondary structure is still disputed. Most authors assume the
presence of six transmembrane segments in this area, but
several models with only four transmembrane segments have
been proposed too (9, 10). In the last transmembrane segment
there is a pair of negatively charged conserved amino acid
residues, but mutational studies up to now give no indication
for an important role in Na1,K1-ATPase (11, 12).
Most negatively charged residues are present in the fifth and
sixth transmembrane segments (see Fig. 1) that are assumed to
be immediately C-terminal of the large intracellular loop. This
region of P-type ATPases, however, is rather peculiar. Because
of the relatively large number of negatively charged and other
polar residues, the hydropathy index is rather low. Moreover,
this region contains a number of proline residues, which gen-
erally give a break in an a-helix structure. In vitro translation
studies with H1,K1-ATPase (13) did not show membrane in-
sertion properties for the fifth and sixth transmembrane seg-
ments. For sarcoplasmic and endoplasmic reticulum
(SERCA)1-type Ca21-ATPase, only a stop-transfer signal was
found for the fifth but not for the sixth transmembrane seg-
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costs of publication of this article were defrayed in part by the payment
of page charges. This article must therefore be hereby marked “adver-
tisement” in accordance with 18 U.S.C. Section 1734 solely to indicate
this fact.
§ To whom correspondence should be addressed. Tel.: 131-24-
3614260; Fax: 131-24-3540525; E-mail: J.dePont@bioch.kun.nl.
1 The abbreviations used are: SERCA, sarcoplasmic and endoplasmic
reticulum Ca21-ATPase; E-P, phosphorylated intermediate; PAGE, poly-
acrylamide gel electrophoresis; PBS, phosphate-buffered saline; SCH28080,
3-(cyanomethyl)-2-methyl8(phenylmethoxy)imidazo[1,2a]pyridine.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 271, No. 47, Issue of November 22, pp. 29764–29772, 1996
© 1996 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www-jbc.stanford.edu/jbc/29764
 at R
adboud Universiteit Nijmegen, on July 9, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
transmembrane segments (14). Lutsenko et al. (15) recently
showed that extensive tryptic digestion of Na1,K1-ATPase led
to membrane release of a water-soluble fragment (Gln737–
Arg829), which included the putative M5-M6 hairpin. Occlusion
of K1, however, prevented the release of this fragment from the
membrane. These findings suggest that (i) the putative trans-
membrane segments M5 and M6 might be present in the mem-
brane in a form different from a classical a-helix and (ii) this
part of the a-subunit plays a role in cation binding and
transport.
The putative M5-M6 region in gastric H1,K1-ATPase con-
tains at least three conserved negatively charged residues
(Glu795, Glu820, and Asp824). Moreover, quite close to the C
terminus of M6 there are three other negatively charged resi-
dues (Glu834, Glu837, and Asp839), which are also conserved in
other ATPases. Although most models for P-type ATPases (16,
17) do not consider these residues as being present in trans-
membrane segments, some models (see Fig. 1) do (18–21). One
of the reasons for the discrepancy between the models for
H1,K1-ATPase and other mammalian P-type ATPases is the
presence of two cysteine residues in the M5-M6 region, at least
one of which is the target for extracellularly applied acid-
activated omeprazole, an inhibitor of gastric acid secretion (19).
Moreover, there is a cytosolically located tryptic digestion site
at Lys791 (19, 20), of which the corresponding amino acid resi-
due in most models is placed within M5. This results in a more
C-terminally located position of the transmembrane segments
M5 and M6 in H1,K1-ATPase as compared with the original
models for Ca21-ATPase and Na1,K1-ATPase (16, 17).
Despite this uncertainty, a number of site-directed mutagen-
esis studies aimed at elucidating the function of these nega-
tively charged residues in the M5-M6 region in Ca21-ATPase of
both the SERCA (3, 5, 22–24) and the plasma membrane type
(25) as well as in Na1,K1-ATPase (26–29) have been performed
recently. From these studies, several candidate amino acids for
a role in transmembrane cation transport have been proposed,
but a consistent model has not yet been obtained.
With the gastric H1,K1-ATPase (18, 21, 30), only one study
with mutants has been published until now (31), since functional
expression of this enzyme system has only recently been success-
fully carried out (31–33). We report here mutational studies in
which six negatively charged amino acid residues within or close
to the fifth and sixth transmembrane segments of the catalytic
subunit have been converted into the corresponding acid amides.
The study shows that the mutation E795Q has no effect, whereas
the mutation D824N, E834Q, E837Q, or D839N prevents the
formation of a phosphorylated intermediate. The mutation
E820Q results in a phosphorylated intermediate with amarkedly
reduced sensitivity toward both K1 and the specific H1,K1-
ATPase inhibitor 3-(cyanomethyl)-2-methyl-8(phenylmethoxy)-
imidazo[1,2a]pyridine (SCH 28080) in the phosphorylation reac-
tion. The hydrolysis of the phosphointermediate is not stimulated
by K1, and no K1-stimulated ATPase activity can be determined.
This emphasizes the importance of these negatively charged res-
idues in the function of H1,K1-ATPase.
EXPERIMENTAL PROCEDURES
Site-directed Mutagenesis—All DNA manipulations were done ac-
cording to standard molecular biology techniques described by Sam-
brook et al. (34). The construct pUC19BglII-HKa (32), containing the
full-length cDNA of the rat H1,K1-ATPase a-subunit was digested with
SphI. After purification from agarose gels, a 1.2-kilobase pair SphI
fragment (base pairs 2238–3400) was inserted in SphI-digested
M13mp18. Nucleotide substitutions were introduced in the rat H1,K1-
ATPase c-DNA according to the method of Vandeyar et al. (35), using
the T7-GEN In Vitro Mutagenesis Kit (U.S. Biochemical Corp.), result-
ing in modification of Glu7953 Gln, Glu8203 Gln, Asp8243 Asn, Glu834
3 Gln, Glu837 3 Gln, and Asp839 3 Asn. Not only a change in the
sequence of rat cDNA as desired was constructed, but also a recogniz-
able sequence of a restriction site was either introduced or deleted.
After selection, digestion with SphI, and purification of the mutant
SphI fragment from agarose gels, this fragment was religated into the
dephosphorylated pUC19BglII-HKaDSphI fragment. The mutated
clones were digested with BglII and DraI, and a 3.3-kilobase pair BglII
fragment was isolated and purified from agarose gels. The baculovirus
transfer vector pAcAS3, containing the code for the b-galactosidase (36),
was digested with BamHI and dephosphorylated. The 3.3-kilobase pair
BglII fragment was ligated into this vector, and the pAcASa mutants
were obtained.
Generation of Recombinant Viruses—The mutated transfer vectors
were used for recombination into the P10 locus of DLZb virus (32)
generating the mutant viruses DLZbASa-E795Q, DLZbASa-D824N,
DLZbASa-E834Q, and DLZbASa-D839N. The viruses were purified
using conventional screening for blue plaques after the addition of
5-bromo-4-chloro-3-indoyl b-D-galactoside to the agarose overlay. Alter-
natively, the transfer vector pAcUW51 (Pharmingen, San Diego, CA)
was used. This vector was digested with BglII, and the dephosphoryl-
ated BamHI fragment of pUC-HKb (32) was cloned into it, yielding the
transfer vector pAcUW51-HKb. After digestion by BamHI and dephos-
phorylation, the 3.3-kilobase pair mutated or wild type BglII fragments,
containing the cDNA of the a-subunit (see above), were ligated into this
vector. After selection via restriction analysis, the pAcUW51-HKba-wt
and pAcUW51-HKba mutants were obtained, with the DNA code of the
a-subunit under control of the polyhedrin promoter and of the b-subunit
under control of the P10 promoter. The mutated transfer vectors and
linearized AcNPV DNA (BaculoGoldTM DNA) were co-transfected in Sf9
cells according to the instructions of the supplier. By this method, the
viruses Bgba-wt, Bgba-E820Q, and Bgba-E837Q were obtained. The
viruses were further purified via a plaque assay and were screened for
the presence of a-subunit by Western blotting. The presence of the
desired mutation in the viral genome was checked by sequence and
restriction analysis of a 391-base pair (2510–2900) polymerase chain
reaction product obtained from viral DNA isolated from nuclei from
infected Sf9 cells. The wild type H1,K1-ATPase obtained by the latter
method showed no difference either on SDS gels or kinetically with the
FIG. 1. Amino acid sequence alignment of the M5-M6 region of the catalytic subunit of various P-type ATPases. The sequences were
obtained for gastric H1,K1-ATPase from Shull et al. (59), for Na1,K1-ATPase from Shull et al. (17), for sarcoplasmic reticulum Ca21-ATPase from
MacLennan et al. (16), and for plasma membrane Ca21-ATPase from Verma et al. (60). The amino acid residues mutated in this study in gastric
H1,K1-ATPase as well as the corresponding amino acid residues in the other ATPases are given in boldface type. The position of the M5 and M6
domains is given according to the original authors except for H1,K1-ATPase and Na1,K1-ATPase, where the models of Klaassen and De Pont (21)
and Lutsenko and Kaplan (2), respectively, are used.
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previous reported H1,K1-ATPase obtained with the conventional bacu-
lovirus method (32, 37).
Production of Recombinant H1,K1-ATPase—Sf9 cells were grown at
27 °C either in 100-ml spinner flask cultures or as monolayer cultures
in 175-cm2 culture flasks as described by Klaassen et al. (32). For
production of H1,K1-ATPase, the cells were infected at a multiplicity of
infection of 3 in the presence of 1% ethanol (37) with the DLZbASa or
Bgba mutated viruses and incubated for 3 days. Occasionally the mul-
tiplicity of infection was varied from 0.01 to 10, and the Sf9 cells were
incubated up to 5 days.
Confocal Laser Scan Microscopy—Sf9 cells were grown on sterile
microscope coverslides in complete growth medium and infected with a
multiplicity of infection of 3 at 27 °C. After infection, cells were incu-
bated at 27 °C for 48 h in complete growth medium with additions as
indicated. Cells were washed three times for 5 min with phosphate-
buffered saline (PBS; pH 7.4) followed by fixation in 1% paraformalde-
hyde in 0.1 M phosphate buffer (pH 7.4) for 1 h at room temperature.
Further processing was done by permeabilization at 220 °C in 100%
methanol for 5 min. Next, the coverslides were dried at room temper-
ature, and aspecific binding sites for antibodies were blocked by incu-
bation for 30–60 min in PBS, 0.05% polyoxyethylene sorbitan mono-
laurate (Tween 20), 1% (w/v) gelatin, and 2% fetal calf serum with
gentle rocking. After washing with PBS, 0.05% Tween 20 three times
for 5 min each, the cells were incubated with the polyclonal antibody
HKB (38) for 30–60 min in PBS, 0.05% Tween 20, 1% (w/v) gelatin, 2%
fetal bovine serum. Free antibodies were removed by washing the cells
as above. Next, the cells were incubated with a fluorescently labeled
secondary antibody (Dako, Glostrup, Denmark) for 1 h in PBS, 0.05%
Tween 20, 1% (w/v) gelatin, and 2% fetal bovine serum. From this
moment on, the coverslides were kept in the dark as much as possible.
After washing as above, the cells were desalted by a short wash with
water, dehydrated with 100% methanol, dried, and mounted in 10%
(w/v) Mowiol (Hoechst, Amsterdam, The Netherlands), 2.5% (w/v)
NaN3, and 25% glycerol in 0.1 M Tris/Cl
2 (pH 8.5). They were examined
on a Bio-RadMRC1000 confocal microscope. Images were averaged over
eight scans.
Preparation of Sf9 Membranes—The Sf9 cells were harvested by
centrifugation at 2,000 3 g for 5 min. After resuspension at 0 °C in 0.25
M sucrose, 2 mM EDTA and 25 mM Hepes/Tris (pH 7.0), the membranes
were sonicated three times for 15 s at 60 W (Branson Power Company,
Denbury, CT). After centrifugation for 30 min at 10,000 3 g, the
supernatant was recentrifugated for 60 min at 100,000 3 g at 4 °C. The
pelleted membranes were resuspended in the above mentioned buffer
and stored at 220 °C.
Protein Determination—Protein was determined with the modified
Lowry method described by Peterson (39) using bovine serum albumin
as a standard.
Quantification of the Expression Level—The H1,K1-ATPase a-sub-
unit content of the membrane fraction was determined by a quantita-
tive enzyme-linked immunosorbent assay (40), using the monoclonal
antibody 5B6 (41, 42) and using purified pig H1,K1-ATPase as
reference.
SDS-PAGE of the Phosphorylated Proteins—After phosphorylation of
50–100 mg of membranes with [g-32P]ATP, the reaction was terminated
upon the addition of 0.5 ml of stopping solution. After a 30-s centrifu-
gation at 16,000 3 g, the pellets were washed with 0.5 ml of 30% (w/v)
sucrose and resuspended in 40 ml of 2 3 concentrated sample buffer,
containing 100 mM Tris-HCl (pH 6.8), 5% dithioerythritol, 4% SDS, 20%
glycerol, and 0.012% bromphenol blue. The protein was solubilized
during a 30-min incubation at room temperature. Samples of 5 ml (2–10
pCi) of 32P-protein, were applied on the SDS-gels (Mini-Protean II;
Bio-Rad). Running gels were prepared with 6% polyacrylamide/N,N9-
bismethylene acrylamide (ratio 40/1.07) in 100 mM Na1-phosphate
buffer (pH 6.5) and 0.2% SDS, while the stacking gel contained 4%
polyacrylamide. In the same 0.1 M Na1-phosphate buffer (pH 6.5), the
electrophoresis was performed at 0 °C, first during 20 min at 30 mV and
next during 3–4 h at 60 mV. The upper electrophoresis buffer also
contained 0.1% SDS. After fixation in 5% (v/v) methanol, 7.5% (v/v)
acetic acid for 15–30 min at room temperature, the gels were autora-
diographed at 220 °C on a Kodak film (X-Omat AR, Eastman Kodak
Co., Rochester, NY), for 3–16 h.
Western Blotting—Protein samples from the membrane fraction were
solubilized in SDS-PAGE sample buffer and separated on SDS-gels
containing 10% acrylamide according to Laemmli (43). For immunoblot-
ting, the separated proteins were transferred to Immobilon polyvinyli-
denedifluoride membranes. The a- and b-subunit of H1,K1-ATPase
were detected as described earlier (32), with the polyclonal antibody
HKB (38) recognizing the 565–585 region of the a-subunit of H1,K1-
ATPase and the monoclonal antibody 2G11 (44) evoked against the
b-subunit of H1,K1-ATPase, respectively.
K1-ATPase Activity Assay—The K1-activated ATPase activity was
determined with a radiochemical method (45). For this purpose, 0.6–5
mg of Sf9 membranes were added to 100 ml of medium, which contained
10 mM [g-32P]ATP (specific activity 100–500 mCizmmol21), 1.0 mM
MgCl2, 0.2 mM EGTA, 0.1 mM EDTA, 0.1 mM ouabain, 1 mM NaN3, 25
mM Tris-HCl (pH 7.0), and varying concentrations of KCl. After incu-
bation for 30 min at 37 °C, the reaction was stopped by adding 500 ml of
ice-cold 10% (w/v) charcoal in 6% (w/v) trichloroacetic acid, and after 10
min at 0 °C, the mixture was centrifuged for 10 s (10,000 3 g). To 0.2 ml
of the clear supernatant, containing the liberated inorganic phosphate
(32Pi), 3 ml of OptiFluor (Canberra Packard, Tilburg, The Netherlands)
was added, and the mixture was analyzed by liquid scintillation anal-
ysis. In general, blanks were prepared by incubating in the absence of
enzyme. The ATPase activity is presented as the percentage of the
activity in the absence of added K1 (5 mM), which is 70–150 nmol of Pi
liberated per mg per h. The latter activity is endogenously present in
membranes of Sf9 cells.
ATP Phosphorylation Capacity—ATP phosphorylation was deter-
mined as described before (37). Sf9 membranes (40–100 mg) were incu-
bated at 0 °C in 25 mM Tris-acetic acid (pH 6.0), 1 mM MgCl2 with and
without 0.1 mM SCH 28080 in 0.2% (v/v) ethanol in a volume of 50 ml.
After 30–60 min of preincubation, 10 ml of 0.6 mM [g-32P]ATP was
added, and the mixture was incubated for another 10 s at 0 °C. The
reaction was stopped by adding 5% trichloroacetic acid in 0.1 M phos-
phoric acid, and the phosphorylated protein was collected by filtration
over a 0.8-mm membrane filter (Schleicher and Schull, Dassel, Germa-
ny). After repeated washing, the filters were analyzed by liquid scintil-
lation analysis. The SCH 28080-sensitive part is defined as the H1,K1-
ATPase-dependent phosphorylation; the activity in the presence of SCH
28080 is the background phosphorylation.
Dephosphorylation Studies—After ATP phosphorylation as described
above, the reaction mixture was diluted from 60 to 200 ml with nonra-
dioactive ATP (final concentration 1 mM) in order to prevent rephos-
phorylation with radioactive ATP and the ligands to be tested (5 mM
ADP, 10 mM K1) (46). The mixture was further incubated for 5 or 10 s
at 0 °C. Thereafter, the reaction was stopped as described above, and
the residual phosphorylation level was determined.
Hydroxylamine Sensitivity of the Phosphorylated Intermediate—Af-
ter ATP phosphorylation, the acid-denaturated membranes present on
the membrane filters were washed with 0.5 M imidazole-HCl (pH 7.5).
After exposure of the filter to either ice-cold 0.5 M hydroxylamine-
imidazole (pH 7.5) or 0.5 M imidazole-HCl (pH 7.5) for 10 min, the
membranes were washed with 5% trichloroacetic acid in 0.1 M phos-
phoric acid and analyzed by liquid scintillation analysis.
Analysis of Data—The I50 values for K
1 and SCH 28080 were itera-
tively determined by fitting the concentration relationship to the logis-
tic equation Y 5 A 1 (B 2 A)/1 1 (10C/10X)D (where A represents the
bottom plateau, B is the top plateau, C is I50, and D is the Hill coeffi-
cient; the values of X and C were entered as the logarithm of concen-
tration) using the nonlinear regression computer program InPlot
(GraphPAD Software for Science, San Diego, CA). All data are pre-
sented as mean values with standard error of the mean, and differences
of average were tested for significance by means of Student’s t test.
Chemicals—[g-32P]ATP (3000 Cizmmol21, Amersham, Buckingham-
shire, UK) was diluted with nonradioactive Tris-ATP (pH 6.0) to a
specific radioactivity of 20–100 Cizmmol21. SCH 28080, kindly provided
by Dr. A. Barnett (Schering-Plough, Bloomfield, NJ), was dissolved in
ethanol and diluted to its final concentration of 0.1 mM in 0.2% ethanol.
The antibodies 2G11, HKB, and HKaC2 were gifts of Drs. J. Forte
(University of California, Berkeley), M. Caplan (Yale University), and
A. Smolka (University of South Carolina), respectively.
RESULTS
Six baculoviruses were produced, each of which contains
coding sequences for the b-subunit as well as for a mutated
a-subunit of gastric H1,K1-ATPase. In each of the mutants,
one of the negatively charged carboxyl residues located in or
around the fifth and sixth transmembrane segments of the
a-subunit had been converted into an acid amide residue.
These viruses were used to infect Sf9 cells. Fig. 2 shows that
the a-subunit present in the membrane fractions of Sf9 cells
infected with these mutated viruses has the same apparent
molecular mass as the a-subunit of the enzyme of pig gastric
mucosa (47). The antibody used to detect the a-subunit on the
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blot (HKB) recognizes a part of the large intracellular loop
between the fourth and the fifth transmembrane segments
(38), a loop that is not mutated in the experiments described in
this paper. All mutants are also recognized by the antibody
HKaC2 (48) directed against the C terminus of the a-subunit
(not shown). This suggests that all mutated a-subunits were
fully expressed and that mutation did not result in enhanced
sensitivity of this subunit for proteolytic breakdown. In all
mutants, both a carbohydrate-free and a core-glycosylated form
of the b-subunit could be detected by the monoclonal antibody
2G11 (Ref. 44; data not shown), as was found earlier for the
wild type enzyme (32).
Mutation of amino acid residues in a protein might not only
affect the function of the protein but could also lead to distur-
bances in the routing process. In the baculovirus system, H,K-
ATPase is, like in the gastric parietal cell, primarily routed to
intracellular membrane vesicles. This can be shown by confocal
laser scan microscopy (Fig. 3). In gastric parietal cells these
vesicles fuse with the apical plasma membrane upon stimula-
tion with agents that increase cyclic AMP or Ca21, but in Sf9
cells this mechanism apparently is absent. Fig. 3 also shows
that in all the mutants the confocal image was similar to that
of the wild type enzyme, indicating that the routing of the
a-subunit was not disturbed.
One of the characteristic properties of the P-type ATPases is
the formation of an acid-stable phosphorylated intermediate
during the catalytic cycle. In gastric H1,K1-ATPase phospho-
rylation occurs upon the addition of Mg21-ATP (45). K1 ions
not only decrease the amount of phosphorylated intermediate
by stimulating the dephosphorylation reaction, but they also
prevent formation of it by shifting the E1 u E2 equilibrium to
the right (45). Fig. 4 (top panel) shows that the presence of such
a phosphorylated protein in the enzyme produced by the wild
type virus can be visualized upon autoradiography after so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis as a
band with an apparent molecular mass of 100 kDa. This band
is absent when 10 mM K1, 0.1 mM SCH 28080, or 1 mM vana-
date was present in the incubation medium before ATP was
added. The specific Na1,K1-ATPase inhibitor ouabain (1 mM)
did not affect the appearance of the 100 kDa band. Fig. 4 shows
an additional band of about 140 kDa in the membrane fraction
obtained from the Sf9 cells infected with the recombinant virus.
This product is absent in the purified pig enzyme but is also
present in the membranes of uninfected Sf9 cells (Fig. 5). The
presence of such a phosphorylated protein explains the rela-
tively high basal phosphorylation capacity in these cells (32). It
is striking that the presence of such a band has not been
reported in studies in which Na1,K1-ATPase (49, 50) has been
expressed with the baculovirus system. In the mutants, the
H1,K1-ATPase-specific phosphorylated intermediate was only
found in the mutants E795Q and E820Q (Fig. 5). No interme-
diate was found in the mutants D824N, E834Q, E837Q, and
FIG. 2. Western blot of H1,K1-ATPase mutants. Membranes
(10–20 mg) isolated from Sf9 cells infected either with wild type virus or
mutated viruses expressing the a- and b-subunits of H1,K1-ATPase
were blotted, and the presence of the a-subunit was detected using the
polyclonal antibody HKB (38). For comparison, the enzyme isolated
from gastric mucosa (pig) and membranes isolated from uninfected cells
are shown.
FIG. 3. Confocal image analysis of sections of Sf9 cells express-
ing H1,K1-ATPase. Sf9 cells were infected with baculoviruses ex-
pressing the (mutated) a-subunit and the b-subunit of H1,K1-ATPase,
and the presence of the a-subunit was visualized as described under
“Experimental Procedures.” Label was found in the cytoplasm around
the nucleus in all mutants and the wild type. The following viruses were
used: uninfected (A), DZ1 (32) (control) (B), Bgba-wt (wild type virus)
(C), DLZbASa-E795Q (D), Bgba-E820Q (E), DLZbASa-D824N (F);
DLZbASa-E834Q (G), Bgba-E837Q (H), and DLZbASa-D839N (I). Bar,
10 mm.
FIG. 4. Autoradiogram of SDS-polyacrylamide gel of the ATP-
phosphorylated Sf9 membranes infected with wild type and
mutated baculoviruses. Membranes isolated from Sf9 cells infected
with wild type virus or the mutant viruses E795Q and E820Q were
phosphorylated at 0 °C with 0.1 mM [g-32P]ATP in the presence of 1 mM
MgCl2 and 20 mM Tris-acetic acid (pH 6.0) after preincubation for 60
min at 0 °C with 100 mM SCH 28080, 10 mM KCl, 1 mM ouabain, or 1 mM
vanadate. The acid-quenched samples were solubilized and subjected to
SDS-PAGE at pH 6.5 as described under “Experimental Procedures.”
Purified pig gastric H1,K1-ATPase was used as control.
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D839N.
The amount of phosphorylated intermediate was measured
both after preincubation with 0.1 mM SCH 28080 and in its
absence and was expressed as pmol of E-P/mg of protein. In the
presence of SCH 28080, the amount of phosphorylated inter-
mediate was in most cases not different between the mutants
and the wild type enzyme (Table I); only with mutant E820Q
this background phosphorylation was significantly higher than
with the wild type enzyme (see below). The difference between
the ATP phosphorylation level in the absence of SCH 28080
and in its presence was taken as the H1,K1-ATPase-specific
phosphorylated intermediate. Table I shows that in the four
mutants in which no 100-kDa phosphoprotein could be seen in
the SDS gels (Fig. 5), the amount of specific phosphorylated
intermediate was not significantly different from zero. The
amount of phosphorylated intermediate of the two mutants of
which a 100-kDa phosphoprotein could be visualized on the
SDS gel (E795Q and E820Q) indeed showed a significant phos-
phorylation capacity.
The amount of H1,K1-ATPase protein expressed was meas-
ured using an enzyme-linked immunosorbent assay (40), based
on specific binding of the produced protein to the monoclonal
antibody 5B6 (41), which recognizes an epitope in the intracel-
lular loop between the fourth and fifth transmembrane domain
of the catalytic subunit of pig gastric H1,K1-ATPase (42). By
comparing the amount of immunoreactive protein with that of
the pig enzyme, the amount of baculovirus-produced (mutated)
H1,K1-ATPase could be quantitated. Table I shows that the
amount of immunoreactive protein in the particulate mem-
brane fractions varied from 0.84 to 4.13% of the total amount of
protein. Although no explanation can be given for this varia-
tion, the table clearly shows that all viruses produced a con-
siderable amount of mutated H1,K1-ATPase protein, indicat-
ing that the lack of activity of the mutants D824N, E834Q,
E837Q, and D839N is not due to lack of biosynthesis. The
amount of phosphorylated intermediate produced by the mu-
tants E795Q and E820Q either expressed per mg of protein or
per mg of H1,K1-ATPase was significantly reduced compared
with the wild type enzyme.
In a series of experiments, the incubation conditions for the
wild type virus have been optimized. The period of infection
and the multiplicity of infection were varied, and in these
experiments both the amount of SCH 28080-sensitive phospho-
rylated intermediate and the amount of immunoreactive
H1,K1-ATPase produced by the insect cells were determined.
Fig. 6 shows that for the wild type enzyme there is a positive
correlation between these two parameters, although individual
experiments do deviate considerably from the calculated re-
gression line. From this kind of experiment the conditions used
in the present study (3 days of infection and a multiplicity of
infection of 3) were chosen. The figure clearly shows that in
addition to the mutants D824N, E834Q, E837Q, and D839N,
which have no measurable phosphorylation capacity, mutant
E795Q has a relatively low phosphorylation capacity, com-
pared with its expression level. The phosphorylation capacity of
mutant E820Q was slightly lower than that of the wild type
enzyme.
The two mutants E795Q and E820Q, which show the pres-
ence of a SCH 28080-sensitive phosphorylated intermediate,
have been studied in more detail. The membranes containing
the (mutated) enzyme were preincubated for 60 min at 0 °C (pH
6.0) with varying concentrations of either K1 or SCH 28080.
Fig. 7A shows that the K1 sensitivity of mutant E795Q (I50 5
0.45 6 0.10 mM; n 5 3), is similar to that of the wild type
enzyme (I50 5 0.38 6 0.04 mM; n 5 5). The I50 value of mutant
E820Q, however, is 10 times higher (I50 5 4.5 6 1.2 mM; n 5 4),
and complete inhibition is not reached at 30 mM. Some reduc-
tion was also found with either 100 mM Na1 or choline1 (not
shown), indicating that the inhibitory effect of high [K1] on the
level of the phosphorylated intermediate of E820Q might even
be in part nonspecific. This mutant has additionally a 100
times lower sensitivity toward SCH 28080 (Fig. 7B). An I50
value of 1.7 6 0.6 mM (n 5 4) was found, whereas the wild type
enzyme has an I50 value of 14 6 3 nM (n 5 4) and mutant
E795Q has an I50 value of 8 6 3 nM (n 5 4).
The effects of K1, SCH 28080, ouabain, and vanadate, if
present during the preincubation step, on the ATP phosphoryl-
ation level are also reflected in the autoradiograms of the
SDS-PAGE gels (Fig. 4, middle and lower panels) of these two
mutants. The figure clearly shows that these reagents have
FIG. 5. Autoradiogram of SDS-polyacrylamide gel of the ATP-
phosphorylated Sf9 membranes infected with mutated recom-
binant baculoviruses. Wild type enzyme and the H1,K1-ATPase
mutants E795Q, E820Q, D824N, E834Q, E837Q, and D839N were
phosphorylated at 0 °C with 0.1 mM [g-32P]ATP in the presence of 1 mM
MgCl2 and 20 mM Tris-acetic acid (pH 6.0). The acid-quenched samples
were solubilized and subjected to SDS-PAGE at pH 6.5 as described
under “Experimental Procedures.” Uninfected Sf9 membranes as well
as gastric H1,K1-ATPase (pig) were used as control.
TABLE I
Properties of Sf9 membranes after infection with recombinant baculovirus
Sf9 cells were infected with recombinant baculoviruses containing the information for either the wild type H1,K1-ATPase or the H1,K1-ATPase
mutants E795Q, E820Q, D824N, E834Q, E837Q, and D839N with a multiplicity of infection of 3. After 72 h, the membranes were isolated, and
the H1,K1-ATPase expression level (percentage of H1,K1-ATPase) and the SCH 28080-sensitive (E-P) and insensitive background (Bkg)
ATP-phosphorylation capacity were determined as described under “Experimental Procedures.” Averages with standard error of the mean for the
indicated number of preparations (n) are presented. Differences of the data compared with the wild type enzyme are tested for significance by
means of Student’s t test (*, p , 0.1; **, p , 0.05; ***, p , 0.01).
mutant n Bkg E-P H1,K1-ATPase E-P
pmol/mg protein pmol/mg protein % of pig enzyme pmol/mg H1,K1-ATPase
Uninfected 5 0.87 6 0.18 20.03 6 0.04 0.00 6 0.00
Wild type enzyme 9 0.69 6 0.09 1.15 6 0.11 1.50 6 0.17 78.1 6 10.2
E795Q 5 0.78 6 0.16 0.65 6 0.12** 4.13 6 0.86*** 19.7 6 6.0
E820Q 4 1.05 6 0.15** 0.52 6 0.04*** 1.86 6 0.45 33.2 6 7.1
D824N 5 0.77 6 0.16 0.04 6 0.02*** 3.13 6 0.82** 2.4 6 1.3
E834Q 6 0.76 6 0.17 20.02 6 0.03*** 1.36 6 0.23 24.5 6 4.0
E837Q 3 0.53 6 0.13 20.03 6 0.05*** 0.84 6 0.28* 29.3 6 8.6
D839N 5 0.67 6 0.08 0.07 6 0.04*** 1.97 6 0.40 4.3 6 1.8
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hardly any effect on the formation of the phosphorylated inter-
mediate of mutant E820Q in contrast to both the wild type
enzyme and mutant E795Q.
The reduced sensitivity of mutant E820Q for SCH 28080 has
another consequence. The background phosphorylation (Table
I, column 2) has been defined as the SCH 28080 (100 mM)
-insensitive phosphorylation capacity. Since SCH 28080 even
at 1 mM is not able to inhibit the formation of the phosphoryl-
ated intermediate of E820Q completely (see Fig. 7B), the back-
ground phosphorylation, attributed to the 140-kDa product,
has been overestimated. This explains the significantly higher
background phosphorylation level of mutant E820Q as com-
pared with the wild type enzyme (Table I) and implicitly sug-
gests that the specific phosphorylation level of this mutant has
been underestimated.
In the above mentioned studies, the effect of K1 on the
specific phosphorylation capacity was investigated by preincu-
bation with this ion, thus preventing formation of a phospho-
rylated intermediate. We next prepared a phosphorylated in-
termediate in the absence of K1 and SCH 28080 and measured
the residual amount of phosphorylated intermediate after in-
cubation for 5 and 10 s in the presence of either K1 or ADP. Fig.
8 shows that the phosphorylated intermediate obtained with
the wild type virus is K1-sensitive as expected. There is hardly
any effect of ADP on the dephosphorylation rate of this phos-
phorylated intermediate, in contrast to the situation with the
pig enzyme, where a small effect has been observed (46). A
similar behavior was found with the E795Q mutant. The
E820Q mutant, however, was insensitive toward added K1 up
to 100 mM. The E820Q mutant also showed no sensitivity for
ADP, suggesting that this mutation did not lead to a blockade
of the E1-P3 E2-P conversion, which would have resulted in an
ADP-sensitive phosphorylated intermediate. Surprisingly, the
SCH 28080-insensitive phosphorylation, which in the SDS gel
is responsible for the band of 140 kDa and is also present in
uninfected cells, also decreased with time. The rate of dephos-
phorylation of this SCH 28080-insensitive phosphoprotein was
increased by ADP but not by the presence of K1 (not shown).
In order to test whether the phosphorylated intermediate of
the wild type enzyme and of the mutants E795Q and E820Q
was an acylphosphate, the intermediate was treated with hy-
droxylamine, which converts the acylphosphate into a hydroxy-
mate (51). Both the wild type enzyme and the mutants E795Q
and E820Q showed similar hydroxylamine sensitivity (Fig. 9),
indicating that also the K1-insensitive mutant E820Q had
formed an acylphosphate as a phosphorylated intermediate.
The figure also shows that the phosphorylated protein present
in the membranes of uninfected Sf9 cells is at least in part an
acylphosphate too. However, a further identification of the
nature of this phosphorylated protein cannot be given. Since
thapsigargin, vanadate, and ouabain have no effect on the level
of this phosphorylated product (not shown) both SERCA-type
FIG. 6. Correlation between the expression level of H1,K1-
ATPase and the SCH 28080-sensitive ATP phosphorylation ca-
pacity of wild type and mutant H1,K1-ATPase membranes. Sf9
cells were infected with viruses expressing the wild type H1,K1-ATPase
and were incubated for 2–5 days with a varying multiplicity of infection
(0.01–10). The expression level (%H1,K1-ATPase) of the obtained mem-
brane preparations is plotted as function of the SCH 28080-dependent
phosphorylation level (squares) and calculated by means of linear re-
gression analysis (y 5 0.48x 1 0.11, r 5 0.78). The mutant H1,K1-
ATPase membrane data (circles) are those from Table I, in which the
multiplicity of infection was 3 and the incubation time was 3 days. The
experiments with the wild type virus in which similar infection and
incubation conditions were used are for comparison given as closed
squares. The open squares represent experiments with wild type virus
using other infection and/or incubation conditions.
FIG. 7. Effects of K1 and SCH 28080 on the ATP phosphoryla-
tion capacity of H1,K1-ATPase obtained from Sf9 membranes
infected with recombinant baculoviruses. Membranes obtained
from Sf9 cells infected with wild type virus (closed circles), mutant
E795Q (open circles), or mutant E820Q (open squares) were preincu-
bated for 60 min at 0 °C in the presence of 1 mM MgCl2 and 20 mM
Tris-acetic acid (pH 6.0) in the presence of either K1 (A) or SCH 28080
(B) in the concentrations indicated. After phosphorylation for 10 s at
0 °C with 0.1 mM [g-32P]ATP, the residual phosphorylation level (E-P)
was determined and expressed as a percentage of the control and
plotted as a function of the K1 or SCH 28080 concentration. Bars
represent S.E. values for three to five experiments.
FIG. 8. Effects of K1 and ADP on the dephosphorylation reac-
tion of the phosphorylated intermediate of H1,K1-ATPase ob-
tained from Sf9 membranes infected with recombinant baculo-
viruses. Membranes obtained from Sf9 cells infected with wild type
virus (A), mutant E795Q (B), and mutant E820Q (C) were phosphoryl-
ated at 0 °C with 0.1 mM [g-32P]ATP in the presence of 1 mM MgCl2 and
20 mM Tris-acetic acid (pH 6.0). After 10 s (t 5 0) the incubation
medium was diluted from 60 to 200 ml with nonradioactive ATP (final
concentration 1 mM) in 25 mM Tris-acetic acid (pH 6.0) in order to
prevent rephosphorylation with radioactive ATP and incubated for
either 5 or 10 s without further addition (squares) or with either 5 mM
ADP (triangles) or 10 mM KCl (circles). The residual phosphorylation
level (E-P) was expressed as a percentage of the control and plotted as
a function of time.
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Ca-ATPases and Na1,K1-ATPase can be excluded as candi-
dates for this 140-kDa protein.
Phosphorylation and dephosphorylation are key steps in the
catalytic cycle of H1,K1-ATPase. Fig. 10 shows the K1 depend-
ence of the overall ATPase activity of membranes of uninfected
Sf9 cells and cells infected with viruses expressing the wild
type enzyme and the mutants E795Q and E820Q. In this assay
a relatively low ATP concentration (10 mM) had to be used in
order to obtain significant stimulation by K1. The wild type
enzyme showed a biphasic activation curve with a maximum at
1 mM K1. This activation could be completely blocked by 100 mM
SCH 28080 (not shown). A similar biphasic activation curve
was found with the pig enzyme using a comparable low (5
versus 10 mM) ATP concentration (45). The E820Q mutant
showed, like the uninfected cells, no K1-dependent ATPase
activity. Low K1 activated the ATPase activity of mutant
E795Q, although the maximal level reached was less than that
of the wild type enzyme, as is also the case for the phosphoryl-
ation capacity of this mutant (Fig. 6). At high K1, however, less
inhibition was found with this mutant than with the wild type
enzyme. The maximal ATPase activity with the wild type en-
zyme was only 60% above the background activity, whereas the
steady-state phosphorylation level was 170% above the control
level (Table I). The relatively minor increase in the ATPase
assay is due to the high basal ATPase activity of the mem-
branes of Sf9 cells. It is tempting to speculate that the high
basal ATPase activity is related to the relatively high dephos-
phorylation rate of uninfected cells in the absence of K1
(Fig. 9).
DISCUSSION
In the present study we converted six negatively charged
amino acid residues present in the M5-M6 region of the a-sub-
unit of gastric H1,K1-ATPase in their acid amide counterpart
as a first approach to establish the importance of these gluta-
mate and aspartate residues for the function of this transport
enzyme. The studies were carried out in the baculovirus sys-
tem, in which we were able to express the enzyme functionally,
by constructing viruses with the (mutated) a-subunit and the
b-subunit behind two different promoters (32, 37). As a main
functional parameter, we measured the presence of a phospho-
rylated intermediate both qualitatively by autoradiography of
the 100-kDa phosphorylated intermediate and quantitatively
by measuring the SCH 28080-sensitive ATP-phosphorylation
level. We also determined the biosynthesis of immunoreactive
a-subunit using a specific enzyme-linked immunosorbent assay
(40). Although the amount of immunoreactive a-subunit varied
considerably from experiment to experiment, we have no indi-
cation that proteolytic breakdown of one of the mutants was
enhanced. Moreover, we have no indication of routing problems
with any of the mutants.
None of the mutants E834Q, E837Q, and D839N showed any
ATP phosphorylation capacity, suggesting that each of these
residues is essential for the enzyme to become phosphorylated.
It might be that these residues are involved in H1 binding,
which is essential for ATP phosphorylation. Similar residues in
other P-type ATPases have met less attention until now, due to
the fact that in nearly all models these residues are located in
the intracellular loop between M6 and M7 and not in trans-
membrane segments (see Fig. 1). Further studies on the precise
location of these residues and mutational studies in other P-
type ATPases are needed to reach more definite conclusions.
The H1,K1-ATPase mutant D824N was also not active in
terms of phosphorylation capacity by ATP. This Asp residue is
completely conserved in Na1,K1-ATPase and Ca21-ATPases
from both sarcoplasmic reticulum and plasma membrane. Mu-
tation of the similar Asp residue in either Na1,K1-ATPase (26,
28) or plasma membrane Ca21-ATPase (25) did not result in
active enzyme either. In SERCA1a Ca21-ATPase, the similar
mutant D800N did not show Ca21 occlusion or Ca21-induced
phosphorylation by ATP (52). Thus, it is possible that this
residue is involved in the binding of cations by all P-type
ATPases, and thus amino acid substitutions affect phosphoryl-
ation from ATP.
Mutation of Glu795 into Gln results in formation of a phos-
FIG. 9. Effect of hydroxylamine on the residual amount of the
phosphorylated intermediate of H1,K1-ATPase obtained from
Sf9 membranes infected with recombinant baculoviruses. Mem-
branes obtained from Sf9 cells either uninfected (triangles) or infected
with wild type virus (circles), mutant E795Q (diamonds), or mutant
E820Q (squares) were phosphorylated at 0 °C with 0.1 mM [g-32P]ATP in
the presence of 1 mM MgCl2 and 20 mM Tris-acetic acid (pH 6.0). The
phosphorylated membranes were treated at pH 7.5 with hydroxylamine
(closed symbols) or imidazole (open symbols) as described under “Ex-
perimental Procedures,” and the residual phosphorylation level (E-P)
was expressed as a percentage of the control and plotted as a function
of time.
FIG. 10. Effect of K1 on the ATPase activity in Sf9 membranes
infected with recombinant baculoviruses. Membranes obtained
from Sf9 cells either uninfected (open triangles) or infected with wild
type virus (circles), mutant E795Q (squares), or mutant E820Q (closed
triangles) were isolated, and the ATPase activity was measured as
described under “Experimental Procedures” with the K1 concentrations
as indicated. In all experiments the activity in the absence of added K1
was set at 100%. Mean values from three experiments with S.E. values
are presented. In the presence of 1.25 mM K1, the ATPase activity of the
wild type enzyme increased by 51 6 7 nmolzmg21zh21, and that of
mutant E795Q increased by 26 6 4 nmolzmg21zh21.
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phorylated intermediate with apparently normal behavior to-
ward K1 and SCH 28080. The amount of this intermediate
formed is smaller than that for the wild type enzyme, as might
be expected from the measurement of immunoreactive a-sub-
unit. This might be due to the production of more inactive
a-subunit. Mutational studies of the similar residue in SERCA
Ca21-ATPase and Na1,K1-ATPase suggest a more important
role of this residue in these two P-type ATPases. The obtained
results, however, markedly depend on the type of the amino
acid residue chosen to replace the glutamate present in these
two enzymes and possibly on the expression system used. Re-
placement of Glu779 into Asp or Leu in Na1,K1-ATPase ex-
pressed in HeLa cells did not result in active enzyme, whereas
mutation of this Glu into Gln or Ala gave an active enzyme (27).
Mutation of the same Glu residue into an Asp, using the bacu-
lovirus system, resulted in an active enzyme with only reduced
cation affinity (29). Replacement of Glu779 by a Lys even re-
sulted in an increase in cation affinity in the latter system.
Moreover, Glu779 in Na1,K1-ATPase is the target for the car-
boxyl-specific reagent 4-(diazomethyl)-7-(diethylamine)-cou-
marin (53, 54), which inactivates the enzyme in a cation-pro-
tective way.
In SERCA Ca21-ATPase, mutation of the corresponding res-
idue, Glu771, into Gln results in inhibition of Ca21 transport (3)
and Ca21 occlusion (55). Phosphorylation from ATP at 2.5 mM
Ca21 and Ca21-induced inhibition of phosphorylation by inor-
ganic phosphate still occurs (22). The dephosphorylation reac-
tion of the ADP-insensitive intermediate was blocked in this
mutant. Mutation of this Glu residue by either Gly or Ala
resulted in similar effects. Replacement of Glu by Lys resulted
in a mutant in which Ca21 had no effect on phosphorylation
from either ATP or inorganic phosphate (56). Moreover the
dephosphorylation step was not inhibited by Ca21 in this mu-
tant. These experiments led Andersen to the suggestion that
Glu771 might participate in countertransport of two protons/
Ca21-ATPase cycle (56).
The most interesting mutant made in the present study is
E820Q. This mutant yields a phosphorylated intermediate
from ATP, but preincubation with either K1 or SCH 28080 had,
in contrast to the wild type enzyme, hardly any effect on the
steady-state ATP phosphorylation level. The hydrolysis of this
phosphorylated intermediate was insensitive to both ADP and
K1, and no K1-activated ATPase activity could be detected in
this mutant. In the pig enzyme, K1 lowers the steady-state
phosphorylation level both by shifting the E1u E2 equilibrium
to the right, which is assumed to occur through a cytosolic K1
binding site (45), and by increasing the rate of dephosphoryl-
ation, which occurs through an extracellular accessible K1
binding site. SCH 28080, a K1 antagonist, is assumed to sta-
bilize the E2 form of the enzyme, thus preventing formation of
a phosphorylated intermediate (57, 58). ADP stimulates hy-
drolysis of an E1-P form of the enzyme (46). The K
1 insensitiv-
ity of the phosphoenzyme of mutant E820Q is not due to inhi-
bition of the E1-P 3 E2-P conversion, since ADP does not
increase the hydrolysis rate of the phosphorylated intermedi-
ate. It is also not due to formation of an abnormal intermediate,
since the hydroxylamine sensitivity of the phosphorylated in-
termediate indicates that also in this mutant an acylphosphate
had been formed. The finding that SCH 28080 does not prevent
formation of a phosphorylated intermediate can be explained
by assuming that the drug is no longer able to convert the
mutated enzyme to the E2 form. A similar explanation can be
given for the fact that vanadate does not completely preclude
ATP phosphorylation. However, the mutation could also affect
the binding of these drugs. The mutation of residue Glu820 thus
affects an extracellularly accessible K1 binding site and possi-
bly also a cytosolically accessible K1-site.
Binding of extracellular K1 to the pig enzyme results in a
long range conformational change, which enhances the hydrol-
ysis rate of the E-P at Asp386. The results presented in this
paper suggest that this process is no longer possible in mutant
E820Q. This suggests that Glu820 is directly involved in K1
binding. There are indications that the similar residue in other
ATPases is also involved in cation binding. In addition, it is
striking that in the K1-sensitive P-type ATPases this residue is
an Asp or a Glu, whereas in the K1-insensitive Ca21-ATPases
this residue is an Asn. In Na1,K1-ATPase, mutation of this
residue (Asp804) into Asn or Glu resulted in an inactive enzyme
as measured by the inability to confer ouabain resistance to
ouabain-sensitive cells (26, 28). In plasma membrane Ca21-
ATPase, mutation of this residue (Asn879) into alanine abol-
ished Ca21 uptake and phosphorylation from ATP (25). In
SERCA1a Ca21-ATPase, the N796A mutation resulted in the
absence of ATP-dependent phosphorylation or Ca21 occlusion,
but the mutant still showed Ca21-dependent inhibition of the
phosphorylation from inorganic phosphate (3). This is ex-
plained by the assumption that for ATP-phosphorylation bind-
ing of two Ca21 ions is necessary, whereas binding of a single
Ca21 ion can already inhibit phosphorylation from inorganic
phosphate (52). All of these studies indicate that in all P-type
ATPases the amino acids present on the site similar to Glu820
are involved in cation binding.
In summary, the present study emphasizes the importance
of Glu820 for coupling between ATP phosphorylation and K1
transport in gastric H1,K1-ATPase. Further studies with this
enzyme are necessary to understand the structural basis for
the specificity of and the kinetic differences between the vari-
ous P-type ATPases.
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